Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Cheryl Shuman and iCAN - Israel-Cannabis Announce Strategic Partnership for CannaTech - International Summit for Accelerating Cannabis Innovation, March 7th & 8th, 2016
  • USA - English


News provided by

Cheryl Shuman Inc.

Feb 15, 2016, 12:30 ET

Share this article

Share toX

Share this article

Share toX

Tel Aviv, Israel and Beverly Hills, CA (PRWEB) February 15, 2016 -- Media personality and cannabis expert Cheryl Shuman and iCAN - Israel Cannabis are pleased to announce a strategic alliance. In this international venture, iCAN and Cheryl Shuman have teamed up to recruit the participation of the biggest influencers in the Cannabis industry for CannaTech, the International Summit for Accelerating Cannabis Innovation March 7th and 8th, 2016 in Tel Aviv and Jerusalem, Israel.

Known as the leading international business development expert the "Martha Stewart of Cannabis", Cheryl Shuman will be speaking at the event as well as hosting international VIP guests. Ms. Shuman will share her experiences working with hundreds of celebrities as brand ambassadors for successful cannabis businesses. This high level event, the first of its kind, is a gathering of global industry leaders and showcases Israel’s contribution to the industry spanning the fields of medicine, research and development, ag-tech, and innovation - CannaTech serves to highlight investment opportunities for the global market.

"We are excited to be working with one of the most recognizable faces in the cannabis industry and creating even more awareness for CannaTech, our premier event for this fast growing industry," said Saul Kaye, CEO and co-founder of iCAN.

The CannaTech Summit, is chaired by Professor Raphael Mechoulam, known world wide as the most influential figure in the field of medical cannabis. He is an organic chemist and professor of Medicinal Chemistry at the Hebrew University of Jerusalem and is involved in a number of local and international medical cannabis research projects.

"As an entrepreneur and female business owner, it’s exciting to be on the ground floor of the Cannabis industry. The partnership with iCAN allows us to showcase Israel as the “Start-Up Cannabis Nation” bringing cannabis innovation to the world,” states Ms. Shuman.

For a complete list of speakers and ticket information, please visit http://www.canna-tech.co.

About iCAN - Israel-Cannabis.com
iCAN is actively engaged in identifying and accelerating cannabis technologies in Israel. The CannaTech Innovation Summit was created to reveal and showcase Israeli medical research, innovation and investment opportunities to a global audience. As Cannabis leaders in Israel we have partnered with both public and private entities to create innovative global brands to power the cannabis economy. To learn more about iCAN, please visit http://www.Israel-Cannabis.com. To learn more about CannaTech, March 7th and 8th, 2016, please visit http://www.canna-tech.co.

About Cheryl Shuman Inc.
Established in 1984, Cheryl Shuman Inc. is a public relations, media, product branding, event production and business development firm focusing on merging mainstream with the cannabis industry. In 2006, Shuman was diagnosed with cancer. After years of following failed allopathic medicine treatments, she opted for medical cannabis in the form of raw juice and oils as an alternative. Her success using medical cannabis led her to found the Beverly Hills Cannabis Club (http://www.BHCClub.com). Today, Cheryl is the most visible and recognizable entrepreneurs in the marijuana reform movement, recently receiving the 2013 Activist of the Year Award at Seattle Hempfest. Cheryl has reached over 100 million viewers worldwide while appearing on such mainstream shows as CNN's Piers Morgan Live, The Katie Couric Show, The View, ABC's 20/20, Good Morning America, Fox Business News and many other media outlets. She was recently featured on the cover of Adweek as Pot's First Marketer as the first company to establish a luxury "Starbucks of Pot" Brand, in Elle Magazine as The Most Potent Women in the Pot Industry, named The Cannabis Queen of Beverly Hills by The New York Times Sunday Magazine as well as gracing the cover of The London Times Magazine as The Cannabis Queen of Beverly Hills. Shuman has also teamed up to launch a luxury cannabis conference series to focus on the affluent cannabis market and high-dollar investment vehicles for the rapidly growing space. Cheryl Shuman is represented for TV, film, book and lecturing deals by the prestigious William Morris Endeavor Agency in Beverly Hills. For more information, please visit: http://www.CherylShuman.com.

Media Contact: Cheryl Shuman, Cheryl(at)CherylShuman(dot)com 310.779.4797

RELATED LINKS
http://www.Israel-Cannabis.com
http://www.Canna-Tech.co
http://www.CherylShuman.com

Cheryl Shuman, Cheryl Shuman Inc., http://www.CherylShuman.com, +1 3107794797, [email protected]

Modal title

Cheryl Shuman is known as the "Martha Stewart of Marijuana"
Cheryl Shuman is known as the "Martha Stewart of Marijuana"
Cheryl Shuman Holds Press Conference on Behalf of Medical Cannabis Patients
Cheryl Shuman Holds Press Conference on Behalf of Medical Cannabis Patients
Cheryl Shuman Business Portrait Mansion
Cheryl Shuman Business Portrait Mansion
10 October 2013 Dr Raphael Mechoulum Israel University of Jerusalam Lab 01948
10 October 2013 Dr Raphael Mechoulum Israel University of Jerusalam Lab 01948
Cheryl Shuman Launches New Marijuana Business Crowdfunding Platform
Cheryl Shuman Launches New Marijuana Business Crowdfunding Platform
Cheryl Shuman Appears on ABC's The View with Barbara Walters
Cheryl Shuman Appears on ABC's The View with Barbara Walters
Steven Tyler of Aerosmith with Cheryl Shuman
Steven Tyler of Aerosmith with Cheryl Shuman
Mother Daughter Marijuana Entrepreneurs Aimee & Cheryl Shuman Announce  Expansion Plans for The Beverly Hills Cannabis Club
Mother Daughter Marijuana Entrepreneurs Aimee & Cheryl Shuman Announce Expansion Plans for The Beverly Hills Cannabis Club
Mother - Daughter Team Aimee Shuman and Cheryl Shuman in Israel
Mother - Daughter Team Aimee Shuman and Cheryl Shuman in Israel
CannaTech Logo
CannaTech Logo
iCan Israel Cannabis Logo
iCan Israel Cannabis Logo
Cheryl Shuman is known as the "Martha Stewart of Marijuana" Cheryl Shuman Holds Press Conference on Behalf of Medical Cannabis Patients Cheryl Shuman Business Portrait Mansion 10 October 2013 Dr Raphael Mechoulum Israel University of Jerusalam Lab 01948 Cheryl Shuman Launches New Marijuana Business Crowdfunding Platform Cheryl Shuman Appears on ABC's The View with Barbara Walters Steven Tyler of Aerosmith with Cheryl Shuman Mother Daughter Marijuana Entrepreneurs Aimee & Cheryl Shuman Announce  Expansion Plans for The Beverly Hills Cannabis Club Mother - Daughter Team Aimee Shuman and Cheryl Shuman in Israel CannaTech Logo iCan Israel Cannabis Logo

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.